The DOI matches its Crossref record; 108 of the 108 references it cites were found in a registry or an index.
A review on the strategies for oral delivery of proteins and peptides and their clinical perspectives
Open accessAbstract
In the modern world, a number of therapeutic proteins such as vaccines, antigens, and hormones are being developed utilizing different sophisticated biotechnological techniques like recombinant DNA technology and protein purification. However, the major glitches in the optimal utilization of therapeutic proteins and peptides by the oral route are their extensive hepatic first-pass metabolism, degradation in the gastrointestinal tract (presence of enzymes and pH-dependent factors), large molecular size and poor permeation. These problems can be overcome by adopting techniques such as chemical transformation of protein structures, enzyme inhibitors, mucoadhesive polymers and permeation enhancers. Being invasive, parenteral route is inconvenient for the administration of protein and peptides, several research endeavors have been undertaken to formulate a better delivery system for proteins and peptides with major emphasis on non-invasive routes such as oral, transdermal, vaginal, rectal, pulmonary and intrauterine. This review article emphasizes on the recent advancements made in the delivery of protein and peptides by a non-invasive (peroral) route into the body.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Protein Therapeutics: A Summary and Pharmacological Classification
Leader, B., Baca, Q. J., & Golan, D. E. (2008) · Nature Reviews Drug Discovery · doi:10.1038/nrd2399 · Cited by 2,161
(2016) · CRC Press eBooks · doi:10.1201/b12801 · Cited by 2,031
The Future of Peptide‐based Drugs
Craik, D. J., Fairlie, D. P., Liras, S., & Price, D. (2013) · Chemical Biology & Drug Design · doi:10.1111/cbdd.12055 · Cited by 1,979
Cell Internalization of the Third Helix of the Antennapedia Homeodomain Is Receptor-independent
Derossi, D., Calvet, S., Trembleau, A., Brunissen, A., Chassaing, G., & Prochiantz, A. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.30.18188 · Cited by 1,073
Strous, G. J., & Dekker, J. (1992) · Critical Reviews in Biochemistry and Molecular Biology · doi:10.3109/10409239209082559 · Cited by 921
Chitosan-based gastrointestinal delivery systems
Hejazi, R., & Amiji, M. (2003) · Journal of Controlled Release · doi:10.1016/s0168-3659(03)00126-3 · Cited by 882
Biologically erodable microspheres as potential oral drug delivery systems
Mathiowitz, E., Jacob, J. S., Jong, Y. S., Carino, G. P., Chickering, D. E., Chaturvedi, P., Santos, C. A., Vijayaraghavan, K., Montgomery, S., Bassett, M., et al. (1997) · Nature · doi:10.1038/386410a0 · Cited by 823
Cell-penetrating peptides: mechanism and kinetics of cargo delivery
Zorko, M., & Langel, Ü. (2005) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2004.10.010 · Cited by 799
Constantinides, P. P. (1995) · Pharmaceutical Research · doi:10.1023/a:1016268311867 · Cited by 742
The use of mucoadhesive polymers in buccal drug delivery
SALAMATMILLER, N., CHITTCHANG, M., & JOHNSTON, T. (2005) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2005.07.003 · Cited by 691
Pan, Y., Li, Y.-J., Zhao, H.-Y., Zheng, J.-M., Xu, H., Wei, G., Hao, J.-S., & Cui, F.-D. (2002) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(02)00486-6 · Cited by 686
Approaches for enhancing oral bioavailability of peptides and proteins
Renukuntla, J., Vadlapudi, A. D., Patel, A., Boddu, S. H. S., & Mitra, A. K. (2013) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2013.02.030 · Cited by 681 · cited 4×
“Currently, only two peptide-and protein-based drugs (Interferon-a and human growth hormone (hGH)) that can be given orally are known to be in clinical development (Renukuntla et al., 2013).”
InfluentialEffects of Oral Insulin in Relatives of Patients With Type 1 Diabetes
The Diabetes Prevention Trial-Type 1 Study Group (2005) · Diabetes Care · doi:10.2337/diacare.28.5.1068 · Cited by 668 · cited 1×
“If HDV-1 is used for a long duration, it becomes tough to control over-glycemic levels due to the development of resistance (Skyler et al., 2005).”
BackgroundThiomers: A new generation of mucoadhesive polymers
BERNKOPSCHNURCH, A. (2005) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2005.07.002 · Cited by 610
Challenges for the oral delivery of macromolecules
Goldberg, M., & Gomez-Orellana, I. (2003) · Nature Reviews Drug Discovery · doi:10.1038/nrd1067 · Cited by 544
Is the oral route possible for peptide and protein drug delivery?
Morishita, M., & Peppas, N. A. (2006) · Drug Discovery Today · doi:10.1016/j.drudis.2006.08.005 · Cited by 515 · cited 9×
“Transport of proteins and peptides have been studied with and without absorption enhancers (Morishita and Peppas, 2006) through buccal epithelia, for example, TRH (Thyrotropin-releasing hormone) and the LHRH (luteinizing hormone-releasing hormone) analogue buserelin, a lauroyl tripeptide, the vasopressin fragment DGAV…”
InfluentialOral Delivery of Peptide Drugs: Barriers and Developments
Hamman, J. H., Enslin, G. M., & Kotz??, A. F. (2005) · BioDrugs · doi:10.2165/00063030-200519030-00003 · Cited by 499
Ponchel, G. (1998) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(98)00040-4 · Cited by 494
Intestinal Permeation Enhancers
Aungst, B. J. (2000) · Journal of Pharmaceutical Sciences · doi:10.1002/(sici)1520-6017(200004)89:4<429::aid-jps1>3.0.co;2-j · Cited by 489
Current challenges in non-invasive insulin delivery systems: A comparative review
Khafagy, E.-S., Morishita, M., Onuki, Y., & Takayama, K. (2007) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2007.08.019 · Cited by 436
P-glycoprotein inhibitors and their screening: a perspective from bioavailability enhancement
Varma, M. (2003) · Pharmacological Research · doi:10.1016/s1043-6618(03)00158-0 · Cited by 418
Thiolated polymers: evidence for the formation of disulphide bonds with mucus glycoproteins
Leitner, V. M., Walker, G. F., & Bernkop-Schnürch, A. (2003) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/s0939-6411(03)00061-4 · Cited by 400
Damgé, C., Michel, C., Aprahamian, M., & Couvreur, P. (1988) · Diabetes · doi:10.2337/diab.37.2.246 · Cited by 390
Tight junction modulation and its relationship to drug delivery
SALAMA, N., EDDINGTON, N., & FASANO, A. (2006) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2006.01.003 · Cited by 357
Emerging Trends in Oral Delivery of Peptide and Protein Drugs
Mahato, R. I., Narang, A. S., Thoma, L., & Miller, D. D. (2003) · Critical Reviews in Therapeutic Drug Carrier Systems · doi:10.1615/critrevtherdrugcarriersyst.v20.i23.30 · Cited by 352
Camenisch, G., Alsenz, J., van de Waterbeemd, H., & Folkers, G. (1998) · European Journal of Pharmaceutical Sciences · doi:10.1016/s0928-0987(97)10019-7 · Cited by 347
Mucoadhesive drug delivery systems
Carvalho, F. C., Bruschi, M. L., Evangelista, R. C., & Gremião, M. P. D. (2010) · Brazilian Journal of Pharmaceutical Sciences · doi:10.1590/s1984-82502010000100002 · Cited by 343
Nakase, I., Takeuchi, T., Tanaka, G., & Futaki, S. (2008) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2007.10.006 · Cited by 342
Polymeric Nanoparticles for Drug Delivery
Chan, J. M., Valencia, P. M., Zhang, L., Langer, R., & Farokhzad, O. C. (2010) · Methods in Molecular Biology · doi:10.1007/978-1-60761-609-2_11 · Cited by 339
Transmucosal macromolecular drug delivery
Prego, C., García, M., Torres, D., & Alonso, M. J. (2005) · Journal of Controlled Release · doi:10.1016/j.jconrel.2004.07.030 · Cited by 338
Yamamoto, A., Taniguchi, T., Rikyuu, K., Tsuji, T., Fujita, T., Murakami, M., & Muranishi, S. (1994) · Pharmaceutical Research · doi:10.1023/a:1018968611962 · Cited by 320
Rieux, A. D., Ragnarsson, E. G. E., Gullberg, E., Préat, V., Schneider, Y.-J., & Artursson, P. (2005) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2005.04.015 · Cited by 298
In vitro and in vivo models for the study of oral delivery of nanoparticles
Gamboa, J. M., & Leong, K. W. (2013) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2013.01.003 · Cited by 285
Nanosphere based oral insulin delivery
Carino, G. P., Jacob, J. S., & Mathiowitz, E. (2000) · Journal of Controlled Release · doi:10.1016/s0168-3659(99)00247-3 · Cited by 278
Fasano, A., & Uzzau, S. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119271 · Cited by 266
Oral protein delivery: Current status and future prospect
Park, K., Kwon, I. C., & Park, K. (2011) · Reactive and Functional Polymers · doi:10.1016/j.reactfunctpolym.2010.10.002 · Cited by 266
Protein and peptide drug delivery: Oral approaches
Shaji, J., & Patole, V (2008) · Indian Journal of Pharmaceutical Sciences · doi:10.4103/0250-474x.42967 · Cited by 262
Enhancing effect of chitosan on peptide drug delivery across buccal mucosa
Şenel, S., Kremer, M. J., Kaş, S., Wertz, P. W., Hıncal, A. A., & Squier, C. A. (2000) · Biomaterials · doi:10.1016/s0142-9612(00)00134-4 · Cited by 256
Safety and efficacy of sodium caprate in promoting oral drug absorption: from in vitro to the clinic
Maher, S., Leonard, T. W., Jacobsen, J., & Brayden, D. J. (2009) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2009.09.006 · Cited by 227
Keynote review: intestinal Peyer's patch M cells and oral vaccine targeting
Brayden, D. J., Jepson, M. A., & Baird, A. W. (2005) · Drug Discovery Today · doi:10.1016/s1359-6446(05)03536-1 · Cited by 224
Peroral Route: An Opportunity for Protein and Peptide Drug Delivery
Sood, A., & Panchagnula, R. (2001) · Chemical Reviews · doi:10.1021/cr000700m · Cited by 222
Basu, A., Yang, K., Wang, M., Liu, S., Chintala, R., Palm, T., Zhao, H., Peng, P., Wu, D., Zhang, Z., et al. (2006) · Bioconjugate Chemistry · doi:10.1021/bc050322y · Cited by 213
Design of nanoparticles composed of graft copolymers for oral peptide delivery
Sakuma, S., Hayashi, M., & Akashi, M. (2001) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(00)00119-8 · Cited by 194
Oral delivery of proteins by biodegradable nanoparticles
Bakhru, S. H., Furtado, S., Morello, A. P., & Mathiowitz, E. (2013) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2013.04.006 · Cited by 190
Donovan, M. D., Flynn, G. L., & Amidon, G. L. (1990) · Pharmaceutical Research · doi:10.1023/a:1015921101465 · Cited by 178
ACARTURK, S. T. (1999) · Journal of Microencapsulation · doi:10.1080/026520499289013 · Cited by 178
MARGOLIN, A. (1996) · Trends in Biotechnology · doi:10.1016/0167-7799(96)10031-7 · Cited by 177
Oral delivery of therapeutic proteins and peptides: a review on recent developments
Gupta, S., Jain, A., Chakraborty, M., Sahni, J. K., Ali, J., & Dang, S. (2013) · Drug Delivery · doi:10.3109/10717544.2013.819611 · Cited by 168
Self-assembled “nanocubicle” as a carrier for peroral insulin delivery
Chung, H., Kim, J., Um, J. Y., Kwon, I. C., & Jeong, S. Y. (2002) · Diabetologia · doi:10.1007/s00125-001-0751-z · Cited by 166
Approaches and Opportunities in Colon-Specific Drug Delivery
Rubinstein, A. (1995) · Critical Reviews in Therapeutic Drug Carrier Systems · doi:10.1615/critrevtherdrugcarriersyst.v12.i2-3.10 · Cited by 166
Shakweh, M., Besnard, M., Nicolas, V., & Fattal, E. (2005) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2005.04.006 · Cited by 161 · cited 3×
“Particle size and surface charge are important factors related to the uptake of particulates by M-cells (Shakweh et al., 2005; Brayden et al., 2005).”
Development of acrylic-based copolymers for oral insulin delivery
Foss, A. C., Goto, T., Morishita, M., & Peppas, N. A. (2004) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/s0939-6411(03)00145-0 · Cited by 161
Oral delivery of therapeutic protein/peptide for diabetes – Future perspectives
Rekha, M. R., & Sharma, C. P. (2012) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2012.03.056 · Cited by 159
TAKKA, F. A. (1999) · Journal of Microencapsulation · doi:10.1080/026520499289022 · Cited by 159
Marschütz, M. K., & Bernkop‐Schnürch, A. (2000) · Biomaterials · doi:10.1016/s0142-9612(00)00039-9 · Cited by 151
Dollo, G., Corre, P. L., Guérin, A., Chevanne, F., Burgot, J. L., & Verge, R. L. (2003) · European Journal of Pharmaceutical Sciences · doi:10.1016/s0928-0987(03)00134-9 · Cited by 148
Oral insulin – a review of current status
Iyer, H. V., Khedkar, A., & Verma, M. (2009) · Diabetes Obesity and Metabolism · doi:10.1111/j.1463-1326.2009.01150.x · Cited by 146
Analysis of the Complexation/Decomplexation Phenomena in Graft Copolymer Networks
Lowman, A. M., & Peppas, N. A. (1997) · Macromolecules · doi:10.1021/ma970399k · Cited by 141
de Coupade, C., Fittipaldi, A., Chagnas, V., Michel, M., Carlier, S., Tasciotti, E., Darmon, A., Ravel, D., Kearsey, J., Giacca, M., et al. (2005) · Biochemical Journal · doi:10.1042/bj20050401 · Cited by 139
Makhlof, A., Werle, M., Tozuka, Y., & Takeuchi, H. (2010) · Journal of Controlled Release · doi:10.1016/j.jconrel.2010.02.001 · Cited by 137
Controlled release by using poly(methacrylic acid-g-ethylene glycol) hydrogels
Peppas, N. A., & Klier, J. (1991) · Journal of Controlled Release · doi:10.1016/0168-3659(91)90044-e · Cited by 137
Cell Penetrating Peptides in the Delivery of Biopharmaceuticals
Munyendo, W. L. L., Lv, H., Benza-Ingoula, H., Baraza, L. D., & Zhou, J. (2012) · Biomolecules · doi:10.3390/biom2020187 · Cited by 128
Jana, S., Mandlekar, S., & Marathe, P. (2010) · Current Medicinal Chemistry · doi:10.2174/092986710793205426 · Cited by 127
BAI, S., Thummel, R., Godwin, A. R. F., Nagase, H., Itoh, Y., Li, T., EVANS, R., McDermott, J. P., Seiki, M., & SARRASJR, M. (2005) · Matrix Biology · doi:10.1016/j.matbio.2005.03.007 · Cited by 117
Development and in vivo evaluation of an oral insulin–PEG delivery system
Calceti, P., Salmaso, S., Walker, G. F., & Bernkop‐Schnürch, A. (2004) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2004.03.015 · Cited by 114
Techniques: New approaches to the delivery of biopharmaceuticals
Orive, G., Rodríguez‐Gascón, A., Hernández, R. M., Domínguez‐Gil, A., & Pedraz, J. L. (2004) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2004.05.006 · Cited by 112
Yoo, H. S., & Park, T. G. (2003) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.10573 · Cited by 110
Incretin-Based Therapies: Review of Current Clinical Trial Data
Peters, A. L. (2010) · The American Journal of Medicine · doi:10.1016/j.amjmed.2009.12.007 · Cited by 107
Oral Delivery of Proteins: Progress and Prognostication
Shah, R. B., Ahsan, F., & Khan, M. A. (2002) · Critical Reviews in Therapeutic Drug Carrier Systems · doi:10.1615/critrevtherdrugcarriersyst.v19.i2.20 · Cited by 100
Tozaki, H., Emi, Y., Horisaka, E., Fujita, T., Yamamoto, A., & Muranishi, S. (1997) · Journal of Pharmacy and Pharmacology · doi:10.1111/j.2042-7158.1997.tb06773.x · Cited by 98
Principles of transmucosal delivery of therapeutic agents
Blanchette, J. O., Kavimandan, N. J., & Peppas, N. A. (2004) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2004.01.006 · Cited by 97
Niosomes for oral delivery of peptide drugs
Yoshida, H., Lehr, C., Kok, W., Junginger, H. E., Verhoef, J. C., & Bouwstra, J. A. (1992) · Journal of Controlled Release · doi:10.1016/0168-3659(92)90016-k · Cited by 96
Kipnes, M. S., Dandona, P., Tripathy, D., Still, J., & Kosutic, G. (2003) · Diabetes Care · doi:10.2337/diacare.26.2.421 · Cited by 96
Formulation and characterization of an oily-based system for oral delivery of insulin
Elsayed, A., Al-Remawi, M. M., Qinna, N. A., Farouk, A., & Badwan, A. A. (2009) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2009.06.004 · Cited by 95
Toorisaka, E. (2003) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(02)00674-9 · Cited by 92
The effect of protein impurities on lysozyme crystal growth
Judge, R. A., Forsythe, E. L., & Pusey, M. L. (1998) · Biotechnology and Bioengineering · Cited by 90
Models to Predict Intestinal Absorption of Therapeutic Peptides and Proteins
Antunes, F., Andrade, F., Ferreira, D., Nielsen, H. M., & Sarmento, B. F. C. C. (2012) · Current Drug Metabolism · doi:10.2174/138920013804545160 · Cited by 89
Karsdal, M. A., Henriksen, K., Bay‐Jensen, A., Molloy, B., Arnold, M., John, M. R., Byrjalsen, I., Azria, M., Riis, B. J., Qvist, P., et al. (2010) · The Journal of Clinical Pharmacology · doi:10.1177/0091270010372625 · Cited by 88
Oral Delivery of Biologically Active Parathyroid Hormone
Leone‐Bay, A., Sato, M., Paton, D. R., Hunt, A. H., Sarubbi, D., Carozza, M., Chou, J., McDonough, J., & Baughman, R. (2001) · Pharmaceutical Research · doi:10.1023/a:1010936227570 · Cited by 87
Walsh, E. G., Adamczyk, B. E., Chalasani, K. B., Maher, S., O‘Toole, E. B., Fox, J. S., Leonard, T. W., & Brayden, D. J. (2011) · Therapeutic Delivery · doi:10.4155/tde.11.132 · Cited by 86
Bernkop‐Schnürch, A., Paikl, C., & Valenta, C. (1997) · Pharmaceutical Research · doi:10.1023/a:1012108118670 · Cited by 85
Clement, S. C., Still, J., Kosutic, G., & McAllister, R. G. (2002) · Diabetes Technology & Therapeutics · doi:10.1089/152091502760306544 · Cited by 84
Oral peptide and protein delivery: unfulfilled promises?
Shen, W. (2003) · Drug Discovery Today · doi:10.1016/s1359-6446(03)02692-8 · Cited by 84
Oral colon-specific drug delivery: a review
den Mooter, G. V., & Kinget, R. (1995) · Drug Delivery · doi:10.3109/10717549509031355 · Cited by 84
Models to Predict Intestinal Absorption of Therapeutic Peptides and Proteins
Antunes, F., Andrade, F., Ferreira, D., Nielsen, H. M., & Sarmento, B. F. C. C. (2012) · Current Drug Metabolism · doi:10.2174/1389200211309010004 · Cited by 84
Vitamin B 12 as a Carrier for the Oral Delivery of Insulin
Petrus, A. K., Vortherms, A. R., Fairchild, T. J., & Doyle, R. P. (2007) · ChemMedChem · doi:10.1002/cmdc.200700239 · Cited by 78
Čilek, A., Çelebi, N., & Tırnaksız, F. (2006) · Drug Delivery · doi:10.1080/10717540500313109 · Cited by 76
The effect of various liposome formulations on insulin penetration across Caco-2 cell monolayer
Değim, Z., Ünal, N., Eşsiz, D., et al. (2004) · Life Sciences · doi:10.1016/j.lfs.2004.05.027 · Cited by 75
A novel per‐oral insulin formulation: proof of concept study in non‐diabetic subjects
Kidron, M., Dinh, S. M., Menachem, Y., Abbas, R., Variano, B., Goldberg, M., Arbit, E., & Bar-On, H. (2004) · Diabetic Medicine · doi:10.1111/j.1464-5491.2004.01160.x · Cited by 74
Aoki, Y., Morishita, M., Asai, K., Akikusa, B., Hosoda, S., & Takayama, K. (2005) · Pharmaceutical Research · doi:10.1007/s11095-005-6137-z · Cited by 67
Use of Targeting Agents to Increase Uptake and Localization of Drugs to the Intestinal Epithelium
Russell-Jones, G. J. (2004) · Journal of drug targeting · doi:10.1080/10611860410001693760 · Cited by 67
Current Prodrug Design for Drug Discovery
Hsieh, P., Hung, C., & Fang, J. (2009) · Current Pharmaceutical Design · doi:10.2174/138161209788682523 · Cited by 64
An Ester Bond Linking a Fragment of a Serine Proteinase to Its Serpin Inhibitor
Egelund, R., Rodenburg, K. W., Andreasen, P. A., Rasmussen, M. S., Guldberg, R. E., & Petersen, T. E. (1998) · Biochemistry · doi:10.1021/bi973043+ · Cited by 63
Targeted lipid based drug conjugates: A novel strategy for drug delivery
Vadlapudi, A. D., Vadlapatla, R. K., Kwatra, D., Earla, R., Samanta, S., Pal, D., & Mitra, A. K. (2012) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2012.05.033 · Cited by 57
Noninvasive Insulin Delivery: the Great Potential of cell-penetrating Peptides
Kamei, N., Nielsen, E. J. B., Khafagy, E., & Takeda‐Morishita, M. (2013) · Therapeutic Delivery · doi:10.4155/tde.12.164 · Cited by 57
Leroux, J., Cozens, R. M., Roesel, J. L., Galli, B., Doelker, É., & Gurny, R. (1996) · Pharmaceutical Research · doi:10.1023/a:1016073416332 · Cited by 54
LeCluyse, E. L., & Sutton, S. C. (1997) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(96)00434-6 · Cited by 51
Cronauer, M. V., Schulz, W. A., Burchardt, T., Anastasiadis, A. G., TAILLE, A. D. L., Ackermann, R., & Burchardt, M. (2003) · International Journal of Oncology · doi:10.3892/ijo.23.4.1095 · Cited by 45
Lee, S., Lee, J., Lee, D. Y., Kim, S., Lee, Y.-J., & Byun, Y. (2005) · Diabetologia · doi:10.1007/s00125-004-1658-2 · Cited by 44
New Developments in Insulin Delivery
Ghilzai, N. M. K. (2003) · Drug Development and Industrial Pharmacy · doi:10.1081/ddc-120018199 · Cited by 44
Lim, C.-J., & Shen, W. (2005) · Journal of Controlled Release · doi:10.1016/j.jconrel.2005.05.001 · Cited by 39
Oral Peptide Delivery: Prioritizing the Leading Technologies
Brayden, D. J., & Mrsny, R. J. (2011) · Therapeutic Delivery · doi:10.4155/tde.11.114 · Cited by 37
Hess, S., Rotshild, V., & Hoffman, A. (2005) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2005.03.003 · Cited by 36
Transport of IGF-I across epithelial cell monolayers
Bastian, S. E. P., WALTON, P. E., Ballard, F. J., & Belford, D. A. (1999) · Journal of Endocrinology · doi:10.1677/joe.0.1620361 · Cited by 34
Wajcberg, E., Miyazaki, Y., Triplitt, C. L., Cersósimo, E., & DeFronzo, R. A. (2004) · Diabetes Care · doi:10.2337/diacare.27.12.2868 · Cited by 34
Kafka, A. P., McLeod, B. J., Rades, T., & McDowell, A. (2010) · Journal of Controlled Release · doi:10.1016/j.jconrel.2010.10.029 · Cited by 26
Evaluation of Skin Damage Caused by Percutaneous Absorption Enhancers Using Fractal Analysis
Obata, Y., Sesumi, T., Takayama, K., Isowa, K., Grosh, S., Wick, S., Sitz, R., & Nagai, T. (2000) · Journal of Pharmaceutical Sciences · Cited by 14
Lee, V. H. L., & Ghandehari, H. (2012) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2012.12.001 · Cited by 9
Cited by
Nanoemulsion: Concepts, development and applications in drug delivery
Singh, Y., Meher, J. G., Raval, K., Khan, F. A., Chaurasia, M., Jain, N. K., & Chourasia, M. K. (2017) · Journal of Controlled Release · doi:10.1016/j.jconrel.2017.03.008 · Cited by 1,358
Food-Derived Bioactive Peptides in Human Health: Challenges and Opportunities
Chakrabarti, S., Guha, S., & Majumder, K. (2018) · Nutrients · doi:10.3390/nu10111738 · Cited by 699
Basic concepts and recent advances in nanogels as carriers for medical applications
Neamtu, I., Rusu, A. G., Diaconu, A., Nita, L. E., & Chiriac, A. P. (2017) · Drug Delivery · doi:10.1080/10717544.2016.1276232 · Cited by 464
A Global Review on Short Peptides: Frontiers and Perspectives
Apostolopoulos, V., Bojarska, J., Chai, T.-T., Elnagdy, S., Kaczmarek, K., Matsoukas, J., New, R., Parang, K., Lopez, O. P., Parhiz, H., et al. (2021) · Molecules · doi:10.3390/molecules26020430 · Cited by 421
Recent advances of controlled drug delivery using microfluidic platforms
Sanjay, S. T., Zhou, W., Dou, M., Tavakoli, H., Ma, L., Xu, F., & Li, X. (2018) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2017.09.013 · Cited by 365
Metadata
- Authors
- Muheem, A., Shakeel, F., Jahangir, M. A., Anwar, M., Mallick, N., Jain, G. K., Warsi, M. H., & Ahmad, F. J.
- Venue
- Saudi Pharmaceutical Journal
- Published
- 2016-07
- Volume
- 24
- Issue
- 4
- Pages
- 413-428
- ISSN
- 1319-0164 (ISSN-L)
- OpenAlex
- W2003859016
- Cited by
- 343
- References
- 108
- FWCI
- 9.28
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.